Alignment Healthcare (NASDAQ:ALHC) Insider Sells $201,324.40 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Robert Scavo sold 11,285 shares of the business’s stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $201,324.40. Following the completion of the sale, the insider owned 487,685 shares of the company’s stock, valued at approximately $8,700,300.40. This represents a 2.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Alignment Healthcare Stock Down 0.2%

Shares of ALHC traded down $0.03 during mid-day trading on Thursday, hitting $18.16. The company’s stock had a trading volume of 3,987,587 shares, compared to its average volume of 2,967,147. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80. The company’s 50-day moving average is $20.57 and its 200-day moving average is $18.78. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The firm has a market capitalization of $3.71 billion, a price-to-earnings ratio of -1,814.19, a PEG ratio of 2.62 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.10. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. Alignment Healthcare’s revenue was up 44.4% compared to the same quarter last year. During the same period last year, the company posted ($0.16) earnings per share. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ALHC shares. Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. Piper Sandler lifted their price objective on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research note on Tuesday, January 6th. TD Cowen upped their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. UBS Group increased their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 14th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $24.56.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ALHC. Teacher Retirement System of Texas boosted its position in Alignment Healthcare by 85.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock worth $1,794,000 after purchasing an additional 47,472 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $3,499,000. Inspire Investing LLC purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at approximately $1,129,000. Cinctive Capital Management LP acquired a new position in shares of Alignment Healthcare in the 3rd quarter valued at $3,814,000. Finally, Ameritas Investment Partners Inc. lifted its stake in shares of Alignment Healthcare by 32.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock valued at $182,000 after purchasing an additional 3,225 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.